Navigation Links
Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
Date:1/31/2011

LOS ANGELES, Jan. 31, 2011 /PRNewswire/ -- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and its parent company Johnson & Johnson, Inc., on January 12, 2011 on behalf of a Los Angeles client. The lawsuit alleges DePuy and Johnson & Johnson designed, manufactured and sold a defective, prosthetic orthopedic implant.

The client, who had to undergo a second complicated hip surgery to replace the defective implant is represented by Attorneys Andrew L. Shapiro, Thomas Cecil, and David B. Bobrosky at Lewitt Hackman. The personal injury attorneys say that in addition to intense pain from the failure of the device which caused a decline in walking and other physical abilities, the client may still suffer from potential metal poisoning and other complications.

According to an August, 2010 article in The New York Times, surgeons implanted about 93,000 ASR XL Acetabular Systems used in traditional hip replacements, and ASR Hip Resurfacing Systems in partial hip replacements, internationally.

The Johnson & Johnson recall was announced nearly two years after the Food and Drug Administration started receiving complaints about the total hip replacement and hip resurfacing devices.  According to The New York Times article, DePuy estimates about 12 to 13 percent of the patients who have the metal on metal hip replacements need a second replacement operation within five years of receiving an ASR implant.

"DePuy's reaction before the recall to the mounting evidence of serious problems with its ASR XL Modular Acetabular Cup System and the DePuy ASR Hip Resurfacing System appears less than forthright," stated attorney Shapiro, adding, "DePuy's questionable pre-recall conduct should certainly make anyone with a DePuy hip implant device think twice about further trusting DePuy to voluntarily pay for all costs of a second surgery and related damages."

Many orthopedic surgeons complain that the hip implant devices are designed improperly, and are extremely difficult to position. Additionally, the very components of the device – cobalt and chrome – also may cause health issues, as the metal on metal wears down within the body.

If you would like to speak with the Los Angeles attorneys handling this case, or if you or someone you know has suffered hip surgery complications related to this Johnson & Johnson recall, please contact Attorneys Andrew Shapiro, Thomas Cecil or David Bobrosky at Lewitt Hackman: 818-907-3223.Media Representatives should call:Chris Podbielski818-907-3271http://www.lewitthackman.com/personal-injury.html
'/>"/>

SOURCE Lewitt Hackman
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and Financial ... financial preparation services, is providing an update on a charitable event that began ... Rescue is a locally recognized nonprofit that provides shelter and care for animals ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
Breaking Medicine News(10 mins):